Double-stranded RNA Activated Caspase Oligomerizer
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:protein
|
| gptkbp:abbreviation |
gptkb:DRACO
|
| gptkbp:canBe |
broad-spectrum antiviral therapy
|
| gptkbp:developedBy |
gptkb:Massachusetts_Institute_of_Technology
gptkb:Todd_Rider |
| gptkbp:firstDescribed |
2011
|
| gptkbp:function |
antiviral drug
|
| https://www.w3.org/2000/01/rdf-schema#label |
Double-stranded RNA Activated Caspase Oligomerizer
|
| gptkbp:mechanismOfAction |
induces apoptosis in virus-infected cells
|
| gptkbp:status |
experimental
|
| gptkbp:target |
double-stranded RNA
|
| gptkbp:bfsParent |
gptkb:DRACO
|
| gptkbp:bfsLayer |
7
|